MICHAEL VASCONCELLES - 29 Dec 2023 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
IMGN
Transactions as of
29 Dec 2023
Net transactions value
+$21,245
Form type
4
Filing time
03 Jan 2024, 17:48:37 UTC
Previous filing
03 Jan 2023
Next filing
05 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $21,245 +1,327 $16.01 1,327 29 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from July 1, 2023 through December 31, 2023.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 3, 2023.